Explore

Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update
Trendline Trendline
PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials
Trendline Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Trendline Trendline
Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026
Trendline Trendline
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston

JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
Trendline Trendline
AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials